Related Experiment Video

Updated: Oct 30, 2025

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia
09:44

Flow Cytometric Analysis of Mitochondrial Reactive Oxygen Species in Murine Hematopoietic Stem and Progenitor Cells and MLL-AF9 Driven Leukemia

Published on: September 5, 2019

7.5K

RSK Isoforms in Acute Myeloid Leukemia

Minyoung Youn1, Jesus Omar Gomez1, Kailen Mark1

  • 1Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA.

Biomedicines
|July 2, 2021
PubMed

Insights

Ribosomal S6 Kinases (RSKs) are key in cell signaling and are overactive in acute myeloid leukemia (AML). Targeting RSKs may offer new therapeutic strategies for AML patients.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Oncology

Background:

  • Ribosomal S6 Kinases (RSKs) are serine/threonine kinases downstream of the Ras/Raf/MEK/ERK pathway.
  • RSKs regulate crucial cellular processes like proliferation, survival, and motility.
  • Aberrant RSK activation is implicated in hematological malignancies, including acute myeloid leukemia (AML).

Purpose of the Study:

  • To review human RSK isoforms.
  • To discuss the role of RSKs in AML pathogenesis.
  • To examine the mechanisms of RSK pharmacological inhibitors.

Main Methods:

  • Literature review of human RSK isoforms.
  • Analysis of RSK involvement in AML.
  • Summary of pharmacological inhibitor mechanisms.

Main Results:

  • RSK isoforms are directly activated by ERK1/2 in response to extracellular signals.
  • High RSK expression and activation in AML correlate with poor outcomes and chemoresistance.
  • RSKs are implicated in regulating diverse cellular functions relevant to cancer.

Conclusions:

  • Understanding RSK function in leukemia is crucial for developing novel therapies.
  • RSK inhibitors show potential as therapeutic strategies for AML.
  • Further research into RSK pathways could uncover new treatment avenues for hematological malignancies.
Keywords:
AMLRSK inhibitorsRSK isoformscancerhematological malignancy

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

380
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.1K

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
58.1K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.6K